JCR Pharmaceuticals Co., Ltd. (4552.T) JPX
463.00
-2(-0.43%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
JCR Pharmaceuticals Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
934
First IPO Date
November 17, 2005
Key Executives
| Name | Title | Pay | Year Born |
| Hiroyuki Fukuya | Exec Off, Dir of Legal & Compliance, Internal Control Dept and Chief Legal & Compliance Off | 0 | N/A |
| Hiroyuki Sonoda | President, Chief Scientific Officer & Representative Director | 0 | 1978 |
| Shin Ashida | Founder & Director | 0 | 1943 |
| Yutaka Honda | Senior Managing Executive Officer, Exec Director of Administration Div. & Head of Exec Office | 0 | N/A |
| Hiroshi Yoshimoto | Senior Advisor | 0 | 1951 |
| Shinji Okamoto | Director of Human Resources Department & Administration Division | 0 | N/A |
| Toru Ashida | Chairman of the Board | 0 | 1968 |
| Yoshihiro Ota | Director of Accounting Department & Corporate Strategy Department (Finance) | 0 | N/A |
| Takafumi Shimizu | Director of Marketing Dept. & Sales Division | 0 | N/A |
| Katsuya Nishino | Executive Vice President | 0 | 1956 |
| Takayo Egawa | Senior Executive Officer & Director of International Affairs | 0 | N/A |
| Tsuyoshi Tajir | Director of Marketing Dept. & Sales Division | 0 | N/A |
Description
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
